Literature DB >> 2262906

A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.

R J Knapp1, L K Vaughn, S N Fang, C L Bogert, M S Yamamura, V J Hruby, H I Yamamura.   

Abstract

[N-methyl-Nle28,31]CCK26-33 (SNF 8702) is a nonsulfated cholecystokinin octapeptide analog that is highly selective for cholecystokinin-B (CCK-B) receptors. Inhibition studies using [125I] Bolton-Hunter-labeled CCK-8 show that SNF 8702 has over 4,000-fold greater affinity for CCK receptors in guinea pig cortex relative to those in guinea pig pancreas. SNF 8702 was tritium-labeled to a specific activity of 23.7 Ci/mmol and its binding properties characterized for guinea pig brain membrane preparations. [3H]SNF 8702 binds to a single site with high affinity (Kd = 0.69-0.90 nM) in guinea pig cortex, cerebellum, hippocampus and pons-medulla. Of these four tissues, the highest receptor density was measured in the cortex (86 fmol/mg of protein) and the lowest in the pons-medulla (22 fmol/mg of protein). In contrast to findings of single-site binding in some brain regions, evidence for CCK-B receptor heterogeneity is observed under other conditions. [3H]SNF 8702 binding to membranes prepared from whole guinea pig brain shows biphasic association kinetics at a concentration of 2.0 nM consistent with the presence of binding site heterogeneity. Binding site heterogeneity is consistently observed for [3H]SNF 8702 binding to guinea pig whole brain membranes in saturation studies where a high-affinity site (Kd = 0.31 nM) is distinguished from a low-affinity site (Kd = 3.3 nM). Binding site heterogeneity is also observed for the midbrain-thalamic region. CCK-B receptor heterogeneity is suggested by the effect of the guanyl nucleotide analogue, guanylyl-imidodiphosphate (Gpp(NH)p), on [3H]SNF 8702 binding to CCK-B receptors in the cerebellum.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2262906

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  New CCK2 agonists confirming the heterogeneity of CCK2 receptors: characterisation of BBL454.

Authors:  Bruno Bellier; Dominique Crété; Marie-Emmanuelle Million; Françoise Beslot; André Bado; Christiane Garbay; Valérie Daugé
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-10-08       Impact factor: 3.000

2.  Analysis of variation in L-365,260 competition curves in radioligand binding assays.

Authors:  E A Harper; S P Roberts; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

Review 3.  On the role of cholecystokinin in pancreatic cancer.

Authors:  M K Herrington; T E Adrian
Journal:  Int J Pancreatol       Date:  1995-04

4.  Cell-type-specific CCK2 receptor signaling underlies the cholecystokinin-mediated selective excitation of hippocampal parvalbumin-positive fast-spiking basket cells.

Authors:  Soo Yeun Lee; Csaba Földy; János Szabadics; Ivan Soltesz
Journal:  J Neurosci       Date:  2011-07-27       Impact factor: 6.167

5.  Multiple N-methylation of MT-II backbone amide bonds leads to melanocortin receptor subtype hMC1R selectivity: pharmacological and conformational studies.

Authors:  Lucas Doedens; Florian Opperer; Minying Cai; Johannes G Beck; Matt Dedek; Erin Palmer; Victor J Hruby; Horst Kessler
Journal:  J Am Chem Soc       Date:  2010-06-16       Impact factor: 15.419

6.  Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.

Authors:  S J Boyle; K W Tang; G N Woodruff; A T McKnight
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

7.  Synthesis and in vitro characterization of radioiodinatable benzodiazepines selective for type 1 and type 2 cholecystokinin receptors.

Authors:  Eyup Akgün; Meike Körner; Fan Gao; Kaleeckal G Harikumar; Beatrice Waser; Jean Claude Reubi; Philip S Portoghese; Laurence J Miller
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

Review 8.  Distinguishing multiple CCK receptor subtypes. Studies with guinea pig chief cells and transfected human CCK receptors.

Authors:  R T Jensen; J M Qian; J T Lin; S A Mantey; J R Pisegna; S A Wank
Journal:  Ann N Y Acad Sci       Date:  1994-03-23       Impact factor: 5.691

Review 9.  CCKB/gastrin receptor antagonists: recent advances and potential uses in gastric secretory disorders.

Authors:  R T Jensen
Journal:  Yale J Biol Med       Date:  1996 May-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.